These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 34237472)

  • 1. In silico analysis of the aggregation propensity of the SARS-CoV-2 proteome: Insight into possible cellular pathologies.
    Flores-León M; Lázaro DF; Shvachiy L; Krisko A; Outeiro TF
    Biochim Biophys Acta Proteins Proteom; 2021 Oct; 1869(10):140693. PubMed ID: 34237472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of SARS-CoV-2 Accessory Proteins to Viral Pathogenicity in K18 Human ACE2 Transgenic Mice.
    Silvas JA; Vasquez DM; Park JG; Chiem K; Allué-Guardia A; Garcia-Vilanova A; Platt RN; Miorin L; Kehrer T; Cupic A; Gonzalez-Reiche AS; Bakel HV; García-Sastre A; Anderson T; Torrelles JB; Ye C; Martinez-Sobrido L
    J Virol; 2021 Aug; 95(17):e0040221. PubMed ID: 34133899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global variation in SARS-CoV-2 proteome and its implication in pre-lockdown emergence and dissemination of 5 dominant SARS-CoV-2 clades.
    Patro LPP; Sathyaseelan C; Uttamrao PP; Rathinavelan T
    Infect Genet Evol; 2021 Sep; 93():104973. PubMed ID: 34147651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of accessory protein variants in the pathogenicity of SARS-CoV-2.
    Hassan SS; Choudhury PP; Dayhoff GW; Aljabali AAA; Uhal BD; Lundstrom K; Rezaei N; Pizzol D; Adadi P; Lal A; Soares A; Mohamed Abd El-Aziz T; Brufsky AM; Azad GK; Sherchan SP; Baetas-da-Cruz W; Takayama K; Serrano-Aroca Ã; Chauhan G; Palu G; Mishra YK; Barh D; Santana Silva RJ; Andrade BS; Azevedo V; Góes-Neto A; Bazan NG; Redwan EM; Tambuwala M; Uversky VN
    Arch Biochem Biophys; 2022 Mar; 717():109124. PubMed ID: 35085577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-Wide Characterization of SARS-CoV-2 Cytopathogenic Proteins in the Search of Antiviral Targets.
    Zhang J; Li Q; Cruz Cosme RS; Gerzanich V; Tang Q; Simard JM; Zhao RY
    mBio; 2021 Feb; 13(1):e0016922. PubMed ID: 35164548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The ORF7b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) is expressed in virus-infected cells and incorporated into SARS-CoV particles.
    Schaecher SR; Mackenzie JM; Pekosz A
    J Virol; 2007 Jan; 81(2):718-31. PubMed ID: 17079322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severe acute respiratory syndrome coronavirus group-specific open reading frames encode nonessential functions for replication in cell cultures and mice.
    Yount B; Roberts RS; Sims AC; Deming D; Frieman MB; Sparks J; Denison MR; Davis N; Baric RS
    J Virol; 2005 Dec; 79(23):14909-22. PubMed ID: 16282490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic and proteomic mutation landscapes of SARS-CoV-2.
    Badua CLDC; Baldo KAT; Medina PMB
    J Med Virol; 2021 Mar; 93(3):1702-1721. PubMed ID: 32970329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of SARS-CoV-2 accessory proteins in immune evasion.
    Zandi M; Shafaati M; Kalantar-Neyestanaki D; Pourghadamyari H; Fani M; Soltani S; Kaleji H; Abbasi S
    Biomed Pharmacother; 2022 Dec; 156():113889. PubMed ID: 36265309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Accessory Proteins in Viral Pathogenesis: Knowns and Unknowns.
    Redondo N; Zaldívar-López S; Garrido JJ; Montoya M
    Front Immunol; 2021; 12():708264. PubMed ID: 34305949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding Individual SARS-CoV-2 Proteins for Targeted Drug Development against COVID-19.
    van de Leemput J; Han Z
    Mol Cell Biol; 2021 Aug; 41(9):e0018521. PubMed ID: 34124934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Silico Study of Mutational Stability of SARS-CoV-2 Proteins.
    Chaudhuri D; Majumder S; Datta J; Giri K
    Protein J; 2021 Jun; 40(3):328-340. PubMed ID: 33890205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homology between SARS CoV-2 and human proteins.
    Khavinson V; Terekhov A; Kormilets D; Maryanovich A
    Sci Rep; 2021 Aug; 11(1):17199. PubMed ID: 34433832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiling of SARS-CoV-2 Subgenomic RNAs in Clinical Specimens.
    Chen Z; Ng RWY; Lui G; Ling L; Chow C; Yeung ACM; Boon SS; Wang MH; Chan KCC; Chan RWY; Hui DSC; Chan PKS
    Microbiol Spectr; 2022 Apr; 10(2):e0018222. PubMed ID: 35311586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
    Mohammed MEA
    Curr Mol Med; 2022; 22(1):50-66. PubMed ID: 33622224
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    Wu S; Tian C; Liu P; Guo D; Zheng W; Huang X; Zhang Y; Liu L
    J Med Virol; 2021 Apr; 93(4):2132-2140. PubMed ID: 33090512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. sgDI-tector: defective interfering viral genome bioinformatics for detection of coronavirus subgenomic RNAs.
    Di Gioacchino A; Legendre R; Rahou Y; Najburg V; Charneau P; Greenbaum BD; Tangy F; van der Werf S; Cocco S; Komarova AV
    RNA; 2022 Mar; 28(3):277-289. PubMed ID: 34937774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole genome analysis of more than 10 000 SARS-CoV-2 virus unveils global genetic diversity and target region of NSP6.
    Saha I; Ghosh N; Pradhan A; Sharma N; Maity D; Mitra K
    Brief Bioinform; 2021 Mar; 22(2):1106-1121. PubMed ID: 33725111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe acute respiratory syndrome coronavirus-2 accessory proteins ORF3a and ORF7a modulate autophagic flux and Ca
    Garrido-Huarte JL; Fita-Torró J; Viana R; Pascual-Ahuir A; Proft M
    Front Microbiol; 2023; 14():1152249. PubMed ID: 37077240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replication Kinetics of B.1.351 and B.1.1.7 SARS-CoV-2 Variants of Concern Including Assessment of a B.1.1.7 Mutant Carrying a Defective ORF7a Gene.
    Pyke AT; Nair N; van den Hurk AF; Burtonclay P; Nguyen S; Barcelon J; Kistler C; Schlebusch S; McMahon J; Moore F
    Viruses; 2021 Jun; 13(6):. PubMed ID: 34200386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.